PharmAI Discovery
PharmAI Discovery is a pioneering company in AI-driven drug discovery, utilizing its proprietary platform, DiscoveryEngine™, to design and develop small-molecule therapeutics. By leveraging atomic-level target data and a virtual library of over 300 million compounds, the company accelerates early discovery, enhances hit rates, and mitigates risks. Their integrated approach includes in vitro and in vivo validation, advancing drug candidates through clinical trials. With a strong focus on innovation and collaboration, PharmAI Discovery has established itself as a leader in the pharmaceutical industry, boasting a 10x higher hit rate than traditional methods and a growing portfolio of pre-clinical assets.
PharmAI Discovery
PharmAI Discovery is a pioneering company in AI-driven drug discovery, utilizing its proprietary platform, DiscoveryEngine™, to design and develop small-molecule therapeutics. By leveraging atomic-level target data and a virtual library of over 300 million compounds, the company accelerates early discovery, enhances hit rates, and mitigates risks. Their integrated approach includes in vitro and in vivo validation, advancing drug candidates through clinical trials. With a strong focus on innovation and collaboration, PharmAI Discovery has established itself as a leader in the pharmaceutical industry, boasting a 10x higher hit rate than traditional methods and a growing portfolio of pre-clinical assets.